![Lois Chandler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lois Chandler
Director de Operaciones en
Taxus Cardium Pharmaceuticals Group, Inc.
.
Perfil
Lois A. Chandler is currently the Chief Operating Officer at Taxus Cardium Pharmaceuticals Group, Inc. She previously worked as the Vice President-Product Development at Activation Therapeutics, Inc. from 2006 to 2019.
Dr. Chandler completed her undergraduate degree at Stanford University and holds a doctorate from the University of Southern California.
Cargos activos de Lois Chandler
| Empresas | Cargo | Inicio |
|---|---|---|
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Director de Operaciones | 01/07/2019 |
Antiguos cargos conocidos de Lois Chandler.
| Empresas | Cargo | Fin |
|---|---|---|
Activation Therapeutics, Inc.
 Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops late-stage clinical and commercial development of regenerative medicine therapeutics | Corporate Officer/Principal | 01/01/2019 |
Formación de Lois Chandler.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
11
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
Activation Therapeutics, Inc.
Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops late-stage clinical and commercial development of regenerative medicine therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Lois Chandler
